Conference Coverage

Women have worse outcomes in cardiogenic shock


 

FROM AHA 2023

Gender-related inequality

In an editorial accompanying publication of the study, Sara Kalantari, MD, and Jonathan Grinstein, MD, University of Chicago, and Robert O. Roswell, MD, Hofstra University, Hempstead, N.Y., said these results “provide valuable information about gender-related inequality in care and outcomes in the management of cardiogenic shock, although the exact mechanisms driving these observed differences still need to be elucidated.

“Broadly speaking, barriers in the care of women with heart failure and cardiogenic shock include a reduced awareness among both patients and providers, a deficiency of sex-specific objective criteria for guiding therapy, and unfavorable temporary mechanical circulatory support devices with higher rates of hemocompatibility-related complications in women,” they added.

“In the era of the multidisciplinary shock team and shock pathways with protocolized management algorithms, it is imperative that we still allow for personalization of care to match the physiologic needs of the patient in order for us to continue to close the gender gap in the care of patients presenting with cardiogenic shock,” the editorialists concluded.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Damar Hamlin’s cardiac arrest: Key lessons
MDedge Emergency Medicine
Angioedema risk jumps when switching HF meds
MDedge Emergency Medicine
Longer diabetes duration links with increased heart failure
MDedge Emergency Medicine
What is the psychological cost of performing CPR?
MDedge Emergency Medicine
Acute cardiac events common during COVID hospitalization
MDedge Emergency Medicine
Cardiac issues twice as likely with COVID plus high troponin
MDedge Emergency Medicine
Wearable fluid sensor lowers risk of HF rehospitalizations: BMAD
MDedge Emergency Medicine
Another FDA class I recall of Cardiosave Hybrid/Rescue IABPs
MDedge Emergency Medicine
Does new heart transplant method challenge definition of death?
MDedge Emergency Medicine
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
MDedge Emergency Medicine